Simulation of repeated dose kinetics of methyl isobutyl ketone in humans from experimental single-dose inhalation exposure.
Methyl isobutyl ketone (MIBK) is a solvent used in numerous products and processes and may be present in the air of the workplace as a vapor. The American Conference of Governmental Industrial Hygienists (ACGIH) threshold limit value-time-weighted average (TLV-TWA) and TLV-short term exposure limit (TLV-STEL) for MIBK are 50 and 75 ppm, respectively. These workplace air concentration limits were set to protect workers from irritation, neurasthenic symptoms and possible adverse effects to their livers and kidneys. A recent revision of the ACGIH limit value has been proposed, to reduce the current TLV-TWA to 30 ppm. This article predicts the kinetics and accumulation of MIBK in humans exposed repeatedly in various exposure scenarios (8, 12, and 24h/day for 7 days) to the current ACGIH TLV-TWA of 50 ppm. The kinetic parameters of the model were derived from published human time-course blood MIBK data from a single 2h inhalation exposure to 48.9 ppm MIBK. The model correctly simulated single exposure experimental data with a rapid rise in blood concentration to 1.06 microg/ml within 1h and approached >or=99% steady-state blood level in 4h of exposure. MIBK was predicted to be rapidly eliminated from blood after terminating the exposure, reaching 0.53 microg/ml and 0.13 microg/ml within 0.5 and 2h post-exposure, respectively. Within 4h after the termination of exposure, blood concentration would be expected to <1% of the steady-state concentration. On the basis of these results, it is concluded that accumulation of MIBK in workers due to repeated inhalation exposure is not likely to occur at the current TLV-TWA concentration of 50 ppm.
Saghir
Shakil A
SA
Toxicology and Environmental Research and Consulting, The Dow Chemical Company, 1803 Building, Midland, MI 48674, USA. ssaghir@dow.com
Rick
David L
DL
D003198:Computer Simulation; D004334:Drug Administration Schedule; D006801:Humans; D019570:Inhalation Exposure; D008452:Maximum Allowable Concentration; D008742:Methyl n-Butyl Ketone / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016273:Occupational Exposure; D012952:Societies; D012997:Solvents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D013997:Time Factors; D014481:United States
D012997:Solvents; D008742:Methyl n-Butyl Ketone; C005458:methyl isobutyl ketone